Olanzapine therapy in treatment-resistant psychotic mood disorders: A long-term follow-up study

Journal of Clinical Psychiatry

Volumn 62, Issue 7, 2001, Pages 509-516

  Narendran, R ^a   Young, C M ^a   Valenti, A M ^a   Pristach, C A ^a   Pato, M T ^a   Grace, J J ^a  

^a ERIE COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

ADULT; AFFECTIVE NEUROSIS; AGED; ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOIDISM; TREATMENT OUTCOME;

EID: 0034884074     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n07a02     Document Type: Article

References (35)

1. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorders, and schizophrenia
2. Clozapine in the treatment of dysphoric mania
3. Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: A report of three cases
4. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania
5. Clozapine for treatment-refractory mania
6. Clozapine in severe mood disorders
7. Antipsychotics in bipolar disorder
8. Clozapine in bipolar disorder: Treatment implications for other atypical antipsychotics
9. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: Review of the empirical literature
10. Radioreceptor binding profile of the atypical antipsychotic olanzapine
11. 2 dopamine receptor occupancy induced by olanzapine in healthy subjects
12. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons
13. Olanzapine's impact on depressive and obsessive compulsive symptoms in schizophrenia
14. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaboration
15. Depressive signs and symptoms in schizophrenia: A prospective blinded trial of olanzapine and haloperidol
16. Olanzapine versus haloperidol in the treatment of schizoaffective bipolar patients
17. Clinical predictors of acute response with olanzapine in psychotic mood disorders
18. Olanzapine response in psychotic depression
19. Olanzapine versus placebo in the treatment of acute mania
20. Is olanzapine a mood-stabilizer?
21. Olanzapine in treatment-resistant bipolar disorder
22. The study of olanzapine plus fluoxetine in treatment-resistant major depressive disorder without psychotic features
23. Olanzapine versus haloperidol in the treatment of schizoaffective disorders
24. Sensitivity of psychiatric diagnosis based on the best estimate procedure
25. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling
26. A comparison of the Kennedy axis V and the global assessment of functioning scale
27. Symptoms and functioning of patients with bipolar disorder six months after hospitalization
28. Modification of the clinical global impressions scale for use in bipolar illness (BP): The CGI-BP
29. Bias in analytic research
30. Controversy in counting and attributing events in clinical trials
31. Clozapine therapy in refractory affective disorders: Polarity predicts response in long-term follow-up
32. The effects of clozapine on aggression and substance abuse in schizophrenic patients
33. Bias and other methodological issues in follow-up (cohort) research studies